Correlation Between Aerovate Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on Aerovate Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and ABVC Biopharma.
Diversification Opportunities for Aerovate Therapeutics and ABVC Biopharma
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and ABVC is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.09 times more return on investment than ABVC Biopharma. However, Aerovate Therapeutics is 1.09 times more volatile than ABVC Biopharma. It trades about 0.01 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.02 per unit of risk. If you would invest 1,571 in Aerovate Therapeutics on August 26, 2024 and sell it today you would lose (1,305) from holding Aerovate Therapeutics or give up 83.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. ABVC Biopharma
Performance |
| Timeline |
| Aerovate Therapeutics |
| ABVC Biopharma |
Aerovate Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and ABVC Biopharma
The main advantage of trading using opposite Aerovate Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |